Zhejiang Anglikang Pharmaceutical Co., Ltd.
Zhejiang Anglikang Pharmaceutical Co., Ltd.
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase IIa Study Evaluating Injectable ALK-N001 in Patients With Advanced Gastrointestinal Tumors | Advanced Gastrointestinal Tumors | Not yet recruiting | Phase 2 | 2026-09-17 | NCT07826195 | |
| A Phase Ib/II Study Evaluating Injectable ALK-N001 in Patients With Advanced Solid Tumors | Advanced Solid Tumors | Not yet recruiting | Phase 1 / Phase 2 | 2026-04-13 | NCT07509684 |